Birmingham, AL8 Active Studies

Major Depressive Disorder Clinical Trials in Birmingham, AL

Find 8 actively recruiting major depressive disorder clinical trials in Birmingham, AL. Connect with local research sites and explore new treatment options.

8
Active Trials
7
Sponsors
2,497
Enrolling

Recruiting Major Depressive Disorder Studies in Birmingham

About Major Depressive Disorder Clinical Trials in Birmingham

Major depressive disorder (MDD) is a severe form of depression characterized by persistent sadness, loss of interest, and impaired daily functioning. Treatment-resistant depression (TRD) affects patients who do not respond to standard therapies. Novel treatments like ketamine, psilocybin, and neuromodulation are being studied.

There are currently 8 major depressive disorder clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 2,497 participants. Research is being sponsored by Janssen Research & Development, LLC, University of Alabama at Birmingham, Cybin IRL Limited and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Major Depressive Disorder Clinical Trials in Birmingham — FAQ

Are there major depressive disorder clinical trials in Birmingham?

Yes, there are 8 major depressive disorder clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What major depressive disorder treatments are being tested?

The 8 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for major depressive disorder.

Data updated October 18, 2026 from ClinicalTrials.gov